Helius Medical Technologies, Inc. (HSDT)
NASDAQ: HSDT · Real-Time Price · USD
6.04
+0.13 (2.29%)
At close: Aug 13, 2025, 4:00 PM
5.90
-0.13 (-2.24%)
Pre-market: Aug 14, 2025, 8:37 AM EDT
HSDT Employees
Helius Medical Technologies had 21 employees as of December 31, 2024. The number of employees decreased by 1 or -4.55% compared to the previous year.
Employees
21
Change (1Y)
-1
Growth (1Y)
-4.55%
Revenue / Employee
$20,667
Profits / Employee
-$622,095
Market Cap
4.11M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
HSDT News
- 24 days ago - Helius Announces Positive Outcome of the Portable Neuromodulation Stimulator PoNS® Stroke Registrational Program and Upcoming Submission to FDA Under Breakthrough Designation - GlobeNewsWire
- 5 weeks ago - Helius Medical Technologies, Inc. Compliant with Nasdaq's Continued Listing Requirements - GlobeNewsWire
- 5 weeks ago - Helius Medical Technologies, Sunrun And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
- 6 weeks ago - Helius Medical Technologies Announces Reverse Stock Split - GlobeNewsWire
- 2 months ago - Helius Medical Technologies, Inc. Announces Claim Authorization by CignaHealth, for its Portable Neuromodulation Stimulator (PoNS®) Device - GlobeNewsWire
- 2 months ago - Positive PoNSTEP Study Results Presented at Consortium of Multiple Sclerosis Centers Annual Meeting - GlobeNewsWire
- 2 months ago - Helius Medical Technologies, Inc. Announces Authorized Claim for Payment by Major Healthcare Payer for its Portable Neuromodulation Stimulator (PoNS®) Device - GlobeNewsWire
- 2 months ago - Helius Medical Technologies Announces Pricing of $9.1 Million Public Offering - GlobeNewsWire